BioIVT

Gain insights into the key elements of metabolic stability studies with Dr. Tina Mueller, Scientific Advisor for #ADME-Tox Services. Explore how species selection and test systems influence outcomes and why these choices are crucial to ensuring your study meets program needs. 🎥 Watch the full video to enhance your understanding of metabolic stability and its impact on drug development: https://hubs.ly/Q037YlKN0 #ADME101 #DrugMetabolism #DrugDevelopment #MetabolicStability

This #BlackHistoryMonth, BioIVT is celebrating the brilliance and contributions of six Black scientists whose groundbreaking discoveries have shaped science and healthcare as we know it.     Learn about these remarkable individuals and their impact on the world ⬇️   #BlackHistory #BlackScientists #ScienceHistory

While cells can be manually isolated in-house from whole blood, tissue and other sources, the process requires expertise, bandwidth &/or capacity that many researchers do not have available. We can fill that gap so you can focus on your research. Our extensive #biospecimens portfolio includes readily-available, high-quality, fresh and cryopreserved cellular material from a diverse range of highly characterized donors, including immune cells and purified subsets like #Tcells. Take a look at the options: https://lnkd.in/eUhcnnp7

Cell and gene therapies are transforming healthcare by tackling diseases at their root. From modifying cells to engineering genes, these therapies hold the potential to cure previously untreatable conditions. By 2033, they’re projected to reach $52.4 billion globally. In pharmaphorum, Lisa Kretzschmar, Senior Scientific Advisor for Cell & Gene Therapy, explores the promise of these therapies, the challenges ahead, and what’s needed to unlock their full potential: https://hubs.ly/Q0378g0t0 #CellandGeneTherapy #ATMPs #CellTherapy #GeneTherapy

Lauren Houghtalin, Lizette Curiel, and Bobbi-Jo Shirley are excited to be at #LBxSanDiego. Lauren will be moderating a session on "Pre-Analytical Insights to Enhance Liquid Biopsy Development Success" today at 5:30pm. Our team is on hand to discuss how #biospecimens quality, donor diversity and data can be utilized to improve accuracy. We provide a wide range of normal and diseased samples across most indications with extensive ready-to-ship inventory and a global network of over 425 clinical sites for custom procurement to meet your needs! To learn more, read the blog post by Courtney Noah, PhD, as she addresses variables, biobanking, and diversity considerations in #LiquidBiopsy research: https://hubs.ly/Q036Z08X0 #LiquidBiopsy #Oncology #CancerResearch #Diagnostics

In a new blog post, DDI expert Dr. Brian Ogilvie provides a detailed outline of updates and discusses the impacts of the recently finalized ICH M12 on #invitro #druginteractions study design and interpretation. The Guideline has replaced corresponding guidance documents from the US FDA, EMA, and PMDA, among others. Make sure your studies meet these new regulatory expectations: https://hubs.ly/Q036Z0q70 #ADME #DMPK #DrugMetabolism #Enzymes #DrugTransporters

#Biospecimens are indispensable tools in #antibody-drug conjugate research, providing important insights into #tumor biology, target validation, and treatment efficacy. Researchers can leverage verified specimens and advanced analytical techniques to accelerate the development of more effective and targeted ADCs, offering new hope for cancer patients worldwide. Cathie G. Miller, PhD discusses important considerations to support successful research and development of ADCs with Drug Discovery World in their Winter 2024/2025 issue ➡️ https://hubs.ly/Q036Z0nJ0 #ADCs #Biomarkers #Oncology #CancerResearch #Efficacy

It was a tremendous honor to be invited by Terumo to speak on the behalf of BIOIVT about the future of Allogeneic Therapies at #Tandem2025. To be speaking in front of a crowd of Cell and Gene Therapy experts with my esteemed colleagues for the panel Dr. John Manis, MD, Associate Director of Transfusion Medicine,Boston Children’s Hospital, Associate Professor of Pathology,Harvard Medical School and Dr. Kate Rochlin, COO of IN8bio was humbling to say the least. With great partners such as BIOIVT, Terumo, Bostons Children's Hospital, and IN8bio the Cell and Gene Therapy Industry is ready to make amazing strides in the future of healthcare worldwide. Many Thanks to Terumo and BIOIVT for allowing me to participate!

We are delighted to welcome Charles Ellis to BioIVT as a Business Development Manager for North America West! With over 10 years of experience in #biotechnology sales and business development, Charles has supported a wide range of innovative solutions, including capital equipment, #bioanalytical services, #CellandGeneTherapy, and custom manufacturing. Charles holds a Master of Science in Biochemistry and a Bachelor of Science in Chemistry and Biochemistry from Florida State University. His deep technical knowledge, combined with a proven ability to drive growth and build strong client relationships, makes him a tremendous resource for supporting customers across all BioIVT products. If you’re in North America West, Charles is here to provide expert support and tailored solutions to advance your research and business goals. Welcome, Charles! We’re thrilled to have you on the team! #WelcomeToBioIVT #BusinessDevelopment #LifeSciences #Innovation

💝 This Valentine’s Day and Donor Day, show some love in a truly meaningful way—by becoming a donor! Your donation helps drive groundbreaking research for diseases like cancer, diabetes, and rheumatoid arthritis, offering hope and brighter futures to those in need. ❤️ Celebrate love and life by giving back. Learn how you can help advance research: https://hubs.ly/Q035YT_p0 #DonorDay #ValentinesDay #ShowSomeLove #TargetACure